NO170691C - Onkofoetale spesifikke monoklonale antistoffer og anvendelse derav - Google Patents

Onkofoetale spesifikke monoklonale antistoffer og anvendelse derav

Info

Publication number
NO170691C
NO170691C NO862920A NO862920A NO170691C NO 170691 C NO170691 C NO 170691C NO 862920 A NO862920 A NO 862920A NO 862920 A NO862920 A NO 862920A NO 170691 C NO170691 C NO 170691C
Authority
NO
Norway
Prior art keywords
oncophetal
monoclonal antibodies
specific monoclonal
specific
antibodies
Prior art date
Application number
NO862920A
Other languages
English (en)
Norwegian (no)
Other versions
NO862920L (no
NO862920D0 (no
NO170691B (no
Inventor
Joseph H Coggin Jr
William J Payne Jr
Original Assignee
Univ South Alabama
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ South Alabama filed Critical Univ South Alabama
Publication of NO862920L publication Critical patent/NO862920L/no
Publication of NO862920D0 publication Critical patent/NO862920D0/no
Publication of NO170691B publication Critical patent/NO170691B/no
Publication of NO170691C publication Critical patent/NO170691C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A61K51/1048—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants the tumor cell determinant being a carcino embryonic antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/948—Microorganisms using viruses or cell lines
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
    • Y10S530/864—Monoclonal

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO862920A 1984-11-21 1986-07-18 Onkofoetale spesifikke monoklonale antistoffer og anvendelse derav NO170691C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/673,794 US4686180A (en) 1984-11-21 1984-11-21 Onco-fetal specific monoclonal antibodies, methods of preparation and use
PCT/US1985/002258 WO1986003223A1 (en) 1984-11-21 1985-11-15 Onco-fetal specific monoclonal antibodies, methods of preparation and use

Publications (4)

Publication Number Publication Date
NO862920L NO862920L (no) 1986-07-18
NO862920D0 NO862920D0 (no) 1986-07-18
NO170691B NO170691B (no) 1992-08-10
NO170691C true NO170691C (no) 1992-11-18

Family

ID=24704144

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862920A NO170691C (no) 1984-11-21 1986-07-18 Onkofoetale spesifikke monoklonale antistoffer og anvendelse derav

Country Status (9)

Country Link
US (1) US4686180A (ja)
EP (1) EP0203967B1 (ja)
JP (1) JPH0683666B2 (ja)
AU (1) AU593229B2 (ja)
CA (1) CA1307218C (ja)
DE (1) DE3583296D1 (ja)
FI (1) FI92222C (ja)
NO (1) NO170691C (ja)
WO (1) WO1986003223A1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675287A (en) * 1984-07-26 1987-06-23 Scripps Clinic And Research Foundation Monoclonal antibody directed to human ganglioside GD2
FR2571146B1 (fr) * 1984-10-01 1988-02-26 Centre Nat Rech Scient Antigenes carcino-foetaux du pancreas humain et un procede de purification, antiserum contre ces antigenes et son procede de preparation et compositions diagnostiques les contenant
US5320941A (en) * 1986-06-06 1994-06-14 Dallan Young DNA sequence encoding mas onhcogene, polypeptides encoded therefrom and diagnostic and other methods based therefrom
JPH0859089A (ja) * 1994-08-18 1996-03-05 Towa Kogyo Kk ボビン搬送用トレイ
ATE432339T1 (de) 1996-04-05 2009-06-15 Univ South Alabama Verwendung von onkofötal-antigen spezifischen cd4,cd8 zytotoxischen, suppressor t-zellen und interleukin-10
US20030124125A1 (en) * 1996-04-05 2003-07-03 South Alabama Medical Science Foundation Oncofetal antigen specific T-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10
DE10346627A1 (de) * 2003-10-08 2005-05-19 Weiss, Stefan, PD Dr. Single-chain-Antikörper gegen den 37 kDa/67 kDa Lamininrezeptor als Werkzeuge zur Diagnose und Therapie von Prionerkrankungen und Krebs, deren Herstellung und Verwendung
GB0510790D0 (en) 2005-05-26 2005-06-29 Syngenta Crop Protection Ag Anti-CD16 binding molecules
WO2007024825A2 (en) * 2005-08-26 2007-03-01 Genway Biotech, Inc. Immunoaffinity separation and analysis compositions and methods
CN116745324A (zh) 2021-01-27 2023-09-12 信达生物制药(苏州)有限公司 针对cd16a的单域抗体及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4440863A (en) * 1978-02-22 1984-04-03 Duke University Breast cyst fluid protein assay
US4272504A (en) * 1978-12-14 1981-06-09 Abbott Laboratories Antibody adsorbed support method for carcinoembryonic antigen assay
US4349528A (en) * 1979-11-21 1982-09-14 The Wistar Institute Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
DE3263249D1 (en) * 1981-08-21 1985-05-30 Hoffmann La Roche Method for the determination of carcinoembryonic antigen (cea) and suitable antibody solution for the determination
JPH0811075B2 (ja) * 1982-06-30 1996-02-07 雄治 松岡 単クローン性抗ｃｅａ抗体

Also Published As

Publication number Publication date
JPS62501189A (ja) 1987-05-14
FI92222C (fi) 1994-10-10
EP0203967B1 (en) 1991-06-19
FI92222B (fi) 1994-06-30
AU593229B2 (en) 1990-02-08
FI862978A0 (fi) 1986-07-18
NO862920L (no) 1986-07-18
FI862978A (fi) 1986-07-18
NO862920D0 (no) 1986-07-18
NO170691B (no) 1992-08-10
WO1986003223A1 (en) 1986-06-05
AU5196486A (en) 1986-06-18
DE3583296D1 (de) 1991-07-25
JPH0683666B2 (ja) 1994-10-26
CA1307218C (en) 1992-09-08
EP0203967A4 (en) 1987-04-10
US4686180A (en) 1987-08-11
EP0203967A1 (en) 1986-12-10

Similar Documents

Publication Publication Date Title
DK666389D0 (da) Monoklonalt antistof
DK401583D0 (da) Parenkymal celle-cellulose og beslaegtede materialer
DK47285A (da) Renininhiberende peptider og anvendelsen deraf
DK391785A (da) Monoklonale antistoffer samt deres fremstilling og anvendelse
EP0240344A3 (en) Monoclonal antibodies and their use
DK63187D0 (da) Krydsbeskyttende monoklonale antistofpraeparater
DK557383D0 (da) Monoclone antistoffer og deres anvendelse
DE3689948D1 (de) Monoklonale antikörper und testverfahren.
DK188185D0 (da) Monoklonalt antistof
NO170691C (no) Onkofoetale spesifikke monoklonale antistoffer og anvendelse derav
EP0285511A3 (en) Monoclonal antibodies and their uses
NO177311C (no) Anti-fucosylceramid monoklonalt antistoff
DE3587714D1 (de) Menschliches alpha 2-Plasmin spezifischer monoklonaler Antikörper.
DK717888D0 (da) Monoklonale antistoffer
DK37785D0 (da) Monoclonalt antistof
DK144485D0 (da) Monoklonale antistoffer
DK474189A (da) Monoklonalt antistof
DK413389D0 (da) Monoklonale antistoffer
DK370089A (da) Anti-urokinase monoklonale antistoffer
DK325183D0 (da) Mumane monoclonale antistoffer og lymfokiner
DK240286A (da) Monoklonale antistoffer
FI923418A0 (fi) Monoklonaalinen vasta-aine
IT1194260B (it) Linfochine e anticorpi monoclonali umani
GB8432502D0 (en) Monoclonal antibody
DK220688D0 (da) Monoklonalt antistof

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MAY 2003